
V Glib 0.3mg Tablet MD
Marketer
Aamorb Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview V Glib 0.3mg Tablet MD
Glib-MD 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating post-prandial hyperglycemia (high blood sugar after meals), particularly when dietary modifications and other anti-diabetic treatments prove insufficient. Glib-MD 0.3mg should be administered immediately prior to meals. Dosage and frequency are determined individually by your physician to optimize blood glucose control. Abrupt cessation should be avoided; discontinuation without medical supervision may elevate blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include bloating, abdominal discomfort, appetite suppression, constipation, and diarrhea. Consult your doctor if these side effects persist or are troublesome. While Glib-MD 0.3mg itself doesn't induce hypoglycemia, combining it with other diabetes medications (especially insulin or sulfonylureas) may increase this risk. Hypoglycemic episodes require treatment with pure glucose; table sugar is ineffective in this context. Inform your physician of any pre-existing liver or kidney conditions before commencing treatment. This medication is contraindicated in individuals with bowel inflammation or ulcers (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating women should seek medical advice prior to use. Always disclose all other medications to your doctor to ensure safe concurrent use. Limit alcohol consumption as it may heighten the risk of hypoglycemia.
Uses of V Glib 0.3mg Tablet MD
Managing type 2 diabetes
Major Benefits of V Glib 0.3mg Tablet MD:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Avoid handling the tablets with damp hands. Allow the 0.3mg V Glib Tablet MD to dissolve in your mouth; do not ingest it whole. Administer on an empty stomach.
Common Side effects of V Glib 0.3mg Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use V Glib 0.3mg Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Avoid contact with the tablets using damp hands. Place the tablet in your mouth, but refrain from swallowing it immediately. V Glib 0.3mg Tablet MD should be consumed on an empty stomach.
How V Glib 0.3mg Tablet MD works:
VGlib 0.3mg Tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thus reducing post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking V Glib 0.3mg Tablet MD is hazardous.
PregnancySAFE IF PRESCRIBED
Pregnancy use of V Glib 0.3mg Tablet MD is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Using V Glib 0.3mg Tablet MD while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by V Glib 0.3mg Tablet MD.
KidneyCAUTION
VGlib 0.3mg tablets (MD) require careful administration for individuals with advanced kidney impairment. Dosage modification of VGlib 0.3mg tablets (MD) might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use V Glib 0.3mg Tablet MD cautiously, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take V Glib 0.3mg Tablet MD :
Omit any missed dose of V Glib 0.3mg Tablet MD and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About V Glib 0.3mg Tablet MD
| Label | Value |
|---|---|
| Type of Compound | Compound derived from valiolamine |
| Potential for Dependence | None. |
| Medication Category | Medication for diabetes |
| Mechanism of Action | Agents that inhibit alpha-glucosidase |
